CClinicalTrials.gg
Active, not recruitingNCT07050290Updated Jul 2, 2026

Restoring Segmental Lumbar Lordosis After Failed Previous Fusion at the Same Level

An interventional study of Restoring segmental lordosis at the lumbar spine in Failed Back Surgery Syndrome, Degeneration Lumbar Spine and Degenerative Spondylolisthesis, sponsored by N.N. Priorov National Medical Research Center of Traumatology and Orthopedics. Active, not recruiting at 1 site in Russia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-02.

Sponsored by N.N. Priorov National Medical Research Center of Traumatology and Orthopedics · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The restoration of lumbar lordosis is mandatory during lumbar fusion surgery for degenerative disc disease, since not restoring lumbar lordosis adequately may adversely affect surgical outcomes and the patient's quality of life in the follow-up. Revision surgery to restore segmental lordosis at the level of previous spinal fusion is extremely difficult to do and its performance is usually inferior to that of primary surgery. Need to provide a surgical technique to restore segmental lordosis via a posterior approach, which is especially important after failed previous fusion at the same lumbar level.

02

Conditions studied

  • Failed Back Surgery Syndrome
  • Degeneration Lumbar Spine
  • Degenerative Spondylolisthesis
  • Sagittal Imbalance

Keywords

  • Lumbar fusion
  • segmental lordosis
  • revision spinal surgery
  • posterior approach
03

In context

Failed Back Surgery Syndrome

98 studies on the registry are indexed under Failed Back Surgery Syndrome; 16 are open to participants now.

This study's planned enrollment of 20 is below the median of 40 across 71 interventional studies indexed under Failed Back Surgery Syndrome.

Browse Failed Back Surgery Syndrome studies →

Lead sponsor

N.N. Priorov National Medical Research Center of Traumatology and Orthopedics is the lead sponsor of 5 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 1. Over 18 years' old;
  • 2. Lumbar back pain with / without radicular leg pain (with / without neurological deficit) with / without neurogenic claudication, symptoms persisting for at least 3 months prior to surgery;
  • 3. 1) Failed back lumbar fusion surgery at the same level or on an adjacent segment or 2) Symptomatic discopathy with loss of segmental lordosis at one of the levels L3-L4, L4-L5 or L5-S1, confirmed by MRI и Rg, with/without degenerative stenosis/spondylolisthesis
  • 4. Need for a planned surgical procedure with a major extent of segmental lordosis restoration (more than 10°);
  • 5. Given written informed consent;
  • 6. Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements

Exclusion criteria

Exclusion Criteria:

  • 1. Interbody implants previously placed via non-posterior approach at the level of surgery (which cannot be removed through the posterior approach);
  • 2. Complete interbody fusion after previous surgery at the level of surgery;
  • 3. HU values of lumbar body vertebrae less than 120 HU;
  • 4. Any contraindication or inability to undergo baseline and/or follow up MRI, CT or X-ray as required per protocol;
  • 5. Back or non-radicular pain of unknown etiology;
  • 6. History or presence of any other major neurological disease or condition that may interfere with the study assessments;
  • 7. Previous enrollment in this study, current enrollment or plans to be enrolled in another study (in parallel to this study).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Other
    Cohort

    All patients will undergo restoring segmental lordosis via one previous posterior approach after failed fusion at the same level.

    Procedure: Restoring segmental lordosis at the lumbar spine

Interventions

  • ProcedureRestoring segmental lordosis at the lumbar spine

    All patients will undergo restoring segmental lordosis via one previous posterior approach after failed fusion at the same level.

06

What researchers measure

Primary outcomes

  1. Change from baseline in lumbar balance parameters

    To observe the change from baseline in segmental lordosis at operated level by CT, in degrees

    Time frame: 2 weeks postoperatively (or at day of hospital discharge)

Secondary outcomes

  1. Change from baseline in Numeric Pain Rating Scale

    To observe the change of Numeric Pain Rating Scale as compared to baseline through follow-up terms (0 - no pain, 10 - unbearable pain)

    Time frame: 2 weeks (or at day of hospital discharge), 3 months, 12 months postoperatively

  2. Change from baseline in Oswestry Disability Index

    To observe the change of Oswestry Disability Index as compared to baseline through follow-up terms (min - 0 - the best result, patient is active; max - 50 - the worst result, patient is not physically active)

    Time frame: 2 weeks (or at day of hospital discharge), 3 months, 12 and 12 months postoperatively

  3. Change from baseline in The Health Transition Item from SF-36

    To observe the The Health Transition Item as compared to baseline through follow-up terms (Patient's answers range from ''Much Better,'' ''Somewhat Better,'' ''About the Same,'' ''Somewhat Worse,'' to ''Much Worse.'')

    Time frame: 2 weeks (or at day of hospital discharge), 3 months, 12 and 12 months postoperatively

  4. Change from baseline in lumbar balance parameters

    To observe the change from baseline in segmental lordosis at operated level by full body X-Ray, in degrees

    Time frame: 3 months and 12 months postoperatively

  5. Change from baseline in lumbar balance parameters

    To observe the change from baseline in low lumbar lordosis (L4-S1) by full body X-Ray, in degrees

    Time frame: 3 months and 12 months postoperatively

  6. Change from baseline in lumbar balance parameters

    To observe the change from baseline in sagittal vertical axis by full body X-Ray, in degrees

    Time frame: 3 months and 12 months postoperatively

  7. Change from baseline in lumbar balance parameters

    To observe the change from baseline in full balance integrated index by full body X-Ray, in degrees

    Time frame: 3 months and 12 months postoperatively

  8. Change from baseline in lumbar balance parameters

    To observe the interbody fusion grade by CT , grades by Tan

    Time frame: 12 months postoperatively

  9. Adverse Events

    Document Adverse Events (incl. adverse events related to device) occurrence throughout the study

    Time frame: during study, an average of 12 months

07

Study locations

1 site
  • Priorov National Medical Research Center of Traumatology and Orthopedics
    Moscow, 127299, Russia
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07050290
Lead sponsor
N.N. Priorov National Medical Research Center of Traumatology and Orthopedics
Responsible party
Sponsor
First posted
Jul 3, 2025
Start date
Jun 25, 2025
Primary completion
Jul 1, 2026
Completion
Jul 1, 2027 (estimated)
Last update
Jul 2, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion